Even if we look past the fact that this method uses ACID as opposed to minimal manipulation in Intellicell's case -- it's just one study. One study means nothing in medicine. Before this technique is proven truly safe and effective, more studies will have to be done, that's at least another year. Even then, since it obtains cells equal to embryonic, the whole thing will most likey stay in academic circles only. But even if some company did want to adopt it commercially, add to that another year or two of commercialization R&D... And they would STILL have to jump through all of the legal hurdles because the process is far from minimal manipulation. So, best case scenario, this process is a soft competitor to Intellicell in 5 years from now - does that sound like something that might impact PPS on Monday?